immunohistochemistry staining method: Clinical Trials

6 trials of immunohistochemistry staining method, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Unknown 2
Phase 21Completed 1

Follow immunohistochemistry staining method: new trials by email Literature Review of immunohistochemistry staining method trials Research Report on immunohistochemistry staining method

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
bevacizumab, cetuximab, fluorouracil - Colorectal Cancer
Phase 2 / Phase 3CompletedMedical Research Council32402009-07-012013-12-19
Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
docetaxel, erlotinib hydrochloride, pemetrexed disodium - Lung Cancer
Phase 3UnknownIstituto Scientifico H. San Raffaele2752008-02-012013-08-12
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
selenium, vitamin E, biopsy - Bladder Cancer
Phase 3UnknownUniversity Hospital Birmingham34002005-12-012014-01-10
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
filgrastim, cyclophosphamide, docetaxel - Breast Cancer
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC18562001-03-012013-10-24
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
immunohistochemistry staining method, biopsy, surgery - Lung Cancer
Phase 3CompletedAlliance for Clinical Trials in Oncology13101999-07-012017-02-16
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
immunohistochemistry staining method, lymphangiography, sentinel lymph node biopsy - Breast Cancer
Phase 3CompletedAlliance for Clinical Trials in Oncology45901999-04-012016-07-13

Conditions studied

Breast Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Lung Neoplasms (2)  ·  Adenocarcinoma of Lung (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Inflammatory Breast Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Sponsors

Alliance for Clinical Trials in Oncology (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Istituto Scientifico H. San Raffaele (1)  ·  Medical Research Council (1)  ·  University Hospital Birmingham (1)

Countries

United Kingdom (3)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Ireland (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)  ·  Slovenia (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Armando E. Giuliano, MD (1)  ·  Herve Bonnefoi (1)  ·  K. K. Cheng, MD (1)  ·  Robbin G. Cohen, MD (1)  ·  Timothy Maughan, MD (1)  ·  Vanesa Gregor, MD (1)

Results publications

PMID 16164916, PMID 16192820, PMID 16514477, PMID 18024211, PMID 20309640, PMID 20667781, PMID 21570352, PMID 21791687, PMID 21990404, PMID 22868365, PMID 24618153, PMID 24831979, PMID 32043193, PMID 34480095